Author:
Genga Kelly R.,Trinder Mark,Russell James A.
Reference133 articles.
1. Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther. 2001;69(3):89-95.
2. Douglas JJ, Roussel JA. The role of genomics to identify biomarkers and signaling molecules during severe sepsis. Minerva Anestesiol. 2016;82(3):343-358.
3. Rhodes A, Evans LE, Alhazzani W, et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017;45(3):486-552.
4. Maslove DM, Wong HR. Gene expression profiling in sepsis: timing, tissue, and translational considerations. Trends Mol Med. 2014;20(4):204-213.
5. Liesenfeld O, Lehman L, Hunfeld KP, Kost G. Molecular diagnosis of sepsis: new aspects and recent developments. Eur J Microbiol Immunol (Bp). 2014;4(1):1-25.